Tagged with Thomas Haselhorst

Researchers have received grants worth over $6.96 million from the Australian Research Council.

Repurposed medications may guide future strategies for COVID-19 treatment.

Griffith’s Institute for Glycomics and Germany’s Bremen University have received funding to continue a research exchange to develop a drug delivery system to treat Non-Hodgkin’s Lymphoma.